766 related articles for article (PubMed ID: 18563785)
21. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
Levin B; Hess K; Johnson C
Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
[TBL] [Abstract][Full Text] [Related]
22. Screening for colorectal cancer.
Mandel JS
Curr Opin Gen Surg; 1994; ():79-84. PubMed ID: 7584018
[TBL] [Abstract][Full Text] [Related]
23. Colorectal cancer screening.
Bretthauer M
J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
25. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
26. The multidisciplinary management of gastrointestinal cancer. Colorectal cancer screening.
Winawer SJ
Best Pract Res Clin Gastroenterol; 2007; 21(6):1031-48. PubMed ID: 18070702
[TBL] [Abstract][Full Text] [Related]
27. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
[TBL] [Abstract][Full Text] [Related]
28. [Screening the population for colorectal cancer: the background to a number of pilot studies in the Netherlands].
van Rijn AF; Dekker E; Kleibeuker JH
Ned Tijdschr Geneeskd; 2006 Dec; 150(50):2739-44. PubMed ID: 17225784
[TBL] [Abstract][Full Text] [Related]
29. Colorectal carcinoma screening procedure use among primary care patients.
Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
[TBL] [Abstract][Full Text] [Related]
30. Potential impact of population-based colorectal cancer screening in Canada.
Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer mortality in two areas of Tuscany with different screening exposures.
Costantini AS; Martini A; Puliti D; Ciatto S; Castiglione G; Grazzini G; Zappa M
J Natl Cancer Inst; 2008 Dec; 100(24):1818-21. PubMed ID: 19066268
[TBL] [Abstract][Full Text] [Related]
32. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a selective screening for colorectal carcinoma: the Taiwan Multicenter Cancer Screening (TAMCAS) project.
Chen TH; Yen MF; Lai MS; Koong SL; Wang CY; Wong JM; Prevost TC; Duffy SW
Cancer; 1999 Oct; 86(7):1116-28. PubMed ID: 10506694
[TBL] [Abstract][Full Text] [Related]
35. Colorectal cancer test use among persons aged > or = 50 years--United States, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Mar; 52(10):193-6. PubMed ID: 12653456
[TBL] [Abstract][Full Text] [Related]
36. Measuring the quality of colorectal cancer screening: the importance of follow-up.
Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of various screening and surveillance methods in colorectal carcinoma].
Burchert A; Schmassmann A
Schweiz Med Wochenschr; 1998 Jun; 128(25):999-1011. PubMed ID: 9691335
[TBL] [Abstract][Full Text] [Related]
38. Survival of patients with colorectal cancer diagnosed in a randomized controlled trial of faecal occult blood screening.
Mapp TJ; Hardcastle JD; Moss SM; Robinson MH
Br J Surg; 1999 Oct; 86(10):1286-91. PubMed ID: 10540135
[TBL] [Abstract][Full Text] [Related]
39. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
40. Increased use of colorectal cancer tests--United States, 2002 and 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):308-11. PubMed ID: 16557215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]